Today
Saturday, 12 SeptemberYour daily brief
8 itemsThe daily brief, by email
What's new in medicine and AI, before rounds
New evidence, approvals, and where AI is actually reaching the clinic — chosen for practising doctors in India. About five minutes, most mornings.
Worth a closer look
Oncologyapproval
The future of RAS inhibitors
RAS inhibitors are moving beyond one approved drug for pancreatic cancer, so expect more targeted options for KRAS-mutant tumours in coming years.
Fierce Biotech21h
Obstetrics & Gynaecologypaper
Effectiveness and Patient Compliance of a Needle-Free Injection System in Controlled Ovarian Stimulation in IVF Cycles: A Real-World, Investigator-Initiated, Retrospective, Multicenter, Observational Study
Needle-free gonadotropin delivery may cut injection pain and cycle dropouts in IVF; this real-world data supports offering it to needle-averse patients.
Cureus24h
Anaesthesiologytrial
Safety and Recovery Profile of Propofol-Based Intravenous Sedation for Endoscopic Retrograde Cholangiopancreatography in Adults: A Prospective Single-Center Observational Study
Prone ERCP limits airway access; this documents respiratory and hemodynamic event rates with propofol sedation so you can anticipate desaturation and recovery timing.
Cureus24h
Neurologypaper
Neurosurgical Outcomes of Epilepsy Surgery Between 2017 and 2025: A Retrospective ESSQ-19 Study From a Tertiary Care Center
Patient-reported satisfaction data from an Indian tertiary centre can help you counsel drug-resistant epilepsy patients weighing surgery against continued drug trials.
Cureus1d
Paediatricsguideline
Pediatric Headache: A Practical Approach to Clinical Diagnosis and Management
Structured four-step approach helps you separate primary from secondary pediatric headache and judge functional impact before referring.
Cureus1d
Obstetrics & Gynaecologyguideline
Factors Influencing Adherence to Mammography Screening Guidelines Among Women From Diverse Cultural Backgrounds: A Systematic Review
Cultural beliefs, language and access barriers drive non-adherence, so ask why a woman has not screened rather than assuming refusal.
Cureus1d